Cosmo Pharmaceuticals (CMOPF) Short Interest Ratio & Short Volume C$64.37 0.00 (0.00%) As of 06/27/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Cosmo Pharmaceuticals Short Interest DataCosmo Pharmaceuticals (CMOPF) has a short interest of 35,800 shares. This marks a -5.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 350 shares to cover all short positions.Current Short Interest35,800 sharesPrevious Short Interest37,800 sharesChange Vs. Previous Month-5.29%Dollar Volume Sold Short$2.30 millionShort Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Today's Trading Volume0 sharesAverage Trading Volume350 sharesToday's Volume Vs. Average0% Short Selling Cosmo Pharmaceuticals? Sign up to receive the latest short interest report for Cosmo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMOPF Short Interest Over TimeCMOPF Days to Cover Over TimeCMOPF Percentage of Float Shorted Over Time Cosmo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202535,800 shares C$2.30 million -5.3%N/A0 $64.37 5/31/202537,800 shares C$2.43 million -12.5%N/A378 $64.37 5/15/202543,200 shares C$2.38 million -35.0%N/A0 $55.00 4/30/202566,500 shares C$3.66 million -4.7%N/A0 $55.00 4/15/202569,800 shares C$3.84 million -4.6%N/A174.5 $55.00 3/14/202590,500 shares C$6.65 million +45.5%N/A452.5 $73.50 2/28/202562,200 shares C$4.57 million +2.1%N/A622 $73.50 2/14/202560,900 shares C$4.42 million +3.6%N/A609 $72.50 1/31/202558,800 shares C$4.16 million +0.2%N/A294 $70.70 1/15/202558,700 shares C$3.93 million -10.0%N/A0 $66.93 CMOPF Short Interest - Frequently Asked Questions What is Cosmo Pharmaceuticals' current short interest? Short interest is the volume of Cosmo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 35,800 shares of CMOPF short. Learn More on Cosmo Pharmaceuticals' current short interest. Is Cosmo Pharmaceuticals' short interest increasing or decreasing? Cosmo Pharmaceuticals saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 35,800 shares, a drop of 5.3% from the previous total of 37,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Cosmo Pharmaceuticals stock? Short selling CMOPF is an investing strategy that aims to generate trading profit from Cosmo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cosmo Pharmaceuticals? A short squeeze for Cosmo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMOPF, which in turn drives the price of the stock up even further. How often is Cosmo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMOPF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies AstraZeneca Short Squeeze CSPC Pharmaceutical Group Short Squeeze JCR Pharmaceuticals Short Squeeze Kyowa Kirin Short Squeeze Mayne Pharma Group Short Squeeze Ono Pharmaceutical Short Squeeze Orion Oyj Short Squeeze Otsuka Short Squeeze Otsuka Short Squeeze PT Kalbe Farma Tbk. Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTC:CMOPF) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmo Pharmaceuticals Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.